Your browser doesn't support javascript.
loading
Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trial.
Gold, Stefan M; Friede, Tim; Meyer, Björn; Moss-Morris, Rona; Hudson, Joanna; Asseyer, Susanna; Bellmann-Strobl, Judith; Leisdon, Andreas; Ißels, Leonie; Ritter, Kristin; Schymainski, David; Pomeroy, Hayley; Lynch, Sharon G; Cozart, Julia S; Thelen, Joan; Román, Cristina A F; Cadden, Margaret; Guty, Erin; Lau, Stephanie; Pöttgen, Jana; Ramien, Caren; Seddiq-Zai, Susan; Kloidt, Anna-Maria; Wieditz, Johannes; Penner, Iris-Katharina; Paul, Friedemann; Sicotte, Nancy L; Bruce, Jared M; Arnett, Peter A; Heesen, Christoph.
Affiliation
  • Gold SM; Klinik für Psychiatrie und Psychotherapie, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; Medizinische Klinik mS Psychosomatik, Charité-Universitätsmedizin Berlin, Freie Universi
  • Friede T; Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
  • Meyer B; Research Department, GAIA AG, Hamburg, Germany.
  • Moss-Morris R; Psychology Department, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
  • Hudson J; Psychology Department, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
  • Asseyer S; NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Bellmann-Strobl J; NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Ber
  • Leisdon A; Klinik für Psychiatrie und Psychotherapie, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Ißels L; Klinik für Psychiatrie und Psychotherapie, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Ritter K; Klinik für Psychiatrie und Psychotherapie, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Schymainski D; Klinik für Psychiatrie und Psychotherapie, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Pomeroy H; Department of Neurology, Cedars Sinai Medical Center, Los Angeles, CA, USA.
  • Lynch SG; Department of Neurology, University of Kansas School of Medicine, Kansas City, KS, USA.
  • Cozart JS; Department of Psychology, University of Missouri-Kansas City, Kansas City, MO, USA.
  • Thelen J; Department of Psychology, University of Missouri-Kansas City, Kansas City, MO, USA.
  • Román CAF; Kessler Foundation, Rutgers New Jersey Medical School, Newark, NJ, USA; Department of Physical Medicine & Rehabilitation, Rutgers New Jersey Medical School, Newark, NJ, USA; Department of Neurology, Rutgers New Jersey Medical School, Newark, NJ, USA.
  • Cadden M; Harvard Medical School, Massachusetts General Hospital/Brigham and Women's Hospital, Boston, MA, USA.
  • Guty E; Department of Psychology, Penn State University, University Park, PA, USA.
  • Lau S; Institut für Neuroimmunologie und Multiple Sklerose, Universitätklinikum Hamburg-Eppendorf, Hamburg, Germany.
  • Pöttgen J; Institut für Neuroimmunologie und Multiple Sklerose, Universitätklinikum Hamburg-Eppendorf, Hamburg, Germany.
  • Ramien C; Institut für Neuroimmunologie und Multiple Sklerose, Universitätklinikum Hamburg-Eppendorf, Hamburg, Germany.
  • Seddiq-Zai S; Institut für Neuroimmunologie und Multiple Sklerose, Universitätklinikum Hamburg-Eppendorf, Hamburg, Germany.
  • Kloidt AM; Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
  • Wieditz J; Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
  • Penner IK; Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Paul F; NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany; Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Ber
  • Sicotte NL; Department of Neurology, Cedars Sinai Medical Center, Los Angeles, CA, USA.
  • Bruce JM; Department of Biomedical and Health Informatics, School of Medicine, University of Missouri-Kansas City, Kansas City, MO, USA.
  • Arnett PA; Department of Psychology, Penn State University, University Park, PA, USA.
  • Heesen C; Institut für Neuroimmunologie und Multiple Sklerose, Universitätklinikum Hamburg-Eppendorf, Hamburg, Germany.
Lancet Digit Health ; 5(10): e668-e678, 2023 10.
Article in En | MEDLINE | ID: mdl-37775187

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cognitive Behavioral Therapy / Depressive Disorder, Major / Multiple Sclerosis Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lancet Digit Health Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cognitive Behavioral Therapy / Depressive Disorder, Major / Multiple Sclerosis Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Lancet Digit Health Year: 2023 Type: Article